Roche Neurology Update 2024 Investor Presentation

Roche held a virtual investor relations event on March 11, 2024, focusing on neurology pipeline updates. The presentation covered late-stage neurology programs including Elevidys in Duchenne Muscular Dystrophy (EMBARK trial) and early-stage neuroscience pipeline developments.